Clinical Trials in Philadelphia

Showing 7641-7660 of 20,904 trials

TERMINATEDPhase 1/2< 1 mile

Fecal Microbial Transplantation for the Treatment of Fecal Incontinence in Women

NCT04201821

Open label pilot study assessing FMT to treat fecal incontinence in women 50 years of age and older.

Fecal Incontinence

University of Pennsylvania10 participantsStarted Jan 2021

Philadelphia, Pennsylvania, United States

COMPLETEDNA< 1 mile

Trim II for Noninvasive Lipolysis and Circumference Reduction of Abdomen.

NCT05398159

At least 90 female and male subjects, from 6 investigational sites, aged 18-70 seeking non-invasive lipolysis and circumference reduction of abdomen will be enrolled. Eligible subjects will receive 3 bi-weekly treatments (once in 2 weeks) with Trim II hands-free applicator belt according to the study protocol.Study duration for each subject is approximately 6 months (including screening, 3 treatments and 2 follow-up visits at 1 and 3 months post last treatment).

Circumference Reduction of Abdomen

InMode MD Ltd.75 participantsStarted Mar 2021

Huntersville, North Carolina, United States • Philadelphia, Pennsylvania, United States • Nashville, Tennessee, United States +2 more locations

COMPLETEDPhase 3< 1 mile

Cellular Immunotherapy in Recipients of HLA-matched, Living Donor Kidney Transplants

NCT03363945

The primary objective of this study is to demonstrate the safety and efficacy of cellular immunotherapy with MDR-101 for induction of functional immune tolerance in recipients of human leukocyte antigen (HLA)-matched, living donor kidney transplants.

Kidney Transplant Rejection

Medeor Therapeutics, Inc.30 participantsStarted Mar 2018

Loma Linda, California, United States • Los Angeles, California, United States • Stanford, California, United States +16 more locations

Fecal Microbial Transplantation for the Treatment of Fecal Incontinence in Women

Trim II for Noninvasive Lipolysis and Circumference Reduction of Abdomen.

Cellular Immunotherapy in Recipients of HLA-matched, Living Donor Kidney Transplants

Find Trials by Condition in Philadelphia

A Phase 3 Study of UGN-102 for Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer

Exploring the Efficacy and Safety of Siponimod in Patients With Secondary Progressive Multiple Sclerosis (EXPAND)

Maternal Cancer Diagnosis and Treatment During Pregnancy:a Database for Maternal, Fetal, and Neonatal Outcomes

Safety and Efficacy Study of Sofpironium Bromide in Subjects With Axillary Hyperhidrosis (BBI-4000-CL-301)

Category Learning Retention in Adults With and Without Developmental Language Disorder

A Study to Examine the Efficacy and Safety of Anti-Fel d 1 Antibodies Injections in Cat-allergic Adolescent and Adult Patients With Allergic Rhinitis Who Live With a Cat

Efficacy and Safety Evaluation of Tavilermide Ophthalmic Solution for the Treatment of Dry Eye

An Observational Biomarker Study in Multiple Sclerosis (MS) Patients

Long-Term Safety of ARQ-154 Foam in Subjects With Seborrheic Dermatitis

Perampanel Titration and Cognitive Effects

Trial for Treatment Refractory Trigeminal Neuralgia

Study of Atezolizumab and Bevacizumab With Y-90 TARE in Patients With Unresectable Hepatocellular Carcinoma (HCC)

Upamostat, a Serine Protease Inhibitor, or Placebo for Treatment of COVID-19 Disease

Study of Trifarotene Cream to Assess Risk of a Trophic Acne Scar Formation

A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

Study of ALVR106 in Patients With Respiratory Viral Infections After Hematopoietic Cell and Solid Organ Transplant

An Open-label Extension Study of an Investigational Drug, Fitusiran, in Patients With Moderate or Severe Hemophilia A or B